Fairvalue-Calculator Fairvalue-Calculator
EN DE

Verano Holdings (VRNO) Fair Value & Analysis

Healthcare · US · Market cap $419M

Price$5.72
Fair Value$9.57
Upside+67.3%
Quality95/100
Evidence: Medium Range $3.97 – $15.74

Fair value as of: Jun 25, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

Verano Holdings (VRNO) currently trades at $5.72, while our model-based Fair Value estimate is $9.57 — implying the stock looks roughly 67.3% undervalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium) — always confirm before acting.

About the company

Verano Holdings Corp. engages in the cannabis business in the United States. It is involved in the cultivation, processing, wholesale, and retail distribution of cannabis. The company also designs, builds, and operates cannabis dispensaries. It sells its products under the Encore, Avexia, MÜV, Savvy, Essence, BITS, HYPHEN, Swift Lifts, Verano, and Zen Leaf brand names to medical and adult use markets. The company is headquartered in Chicago, Illinois.

Open the full interactive analysis →

Similar stocks

Takeda Pharmaceutical Company (TAKP34) +1949% Jiangsu Hengrui Pharmaceuticals Co (600276) -46% Sun Pharmaceutical Industries Limited (SUNPHARMA) -44% Zoetis Inc (Z1TS34) -74% Hansoh Pharmaceutical Group (3692) -47% Divi's Laboratories Limited (DIVISLAB) -70%

Frequently asked questions

Is Verano Holdings (VRNO) undervalued?
As of Jun 25, 2026, our model estimates a fair value of $9.57 versus a price of $5.72 — about +67% (undervalued). Model-based estimate, not financial advice.
What is the fair value of VRNO?
Our 21-model fair value for Verano Holdings is $9.57 (as of Jun 25, 2026), built from audited fundamentals. The current price is $5.72.
What is the quality score of VRNO?
Verano Holdings has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.